NCT01611142 - Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Peripheral T-Cell Lymphoma

Interventions

BIOLOGICAL

KW-0761 (mogamulizumab)

1 mg/kg administered intravenously weekly x 4 then every other week until progression

Trial Locations (15)

Aarhus University Hospital, Aarhus

Hospital Univesitario 12 de Octubre, Madrid

Hospital Clínico Universitario de Salamanca, Salamanca

CHRU Lille, Lille

Centre Hospitaliser de Lyon Sud, Pierre-Bénite

Hopital Saint-Louis, Paris

Centre Henri Becquerel, Rouen

CHU Henri Mondor, Créteil

Università di Bologna, Bologna

Vrije Universiteit Medisch Centrum (VUMC), Amsterdam

Universitair Medisch Centrum Groningen (UMCG), Groningen

Institut Catalá D'Oncologia, Hospital Duran y Reynals, Barcelona

Guy's Hospital, London

Christie Hospital, Manchester

Cancer Research UK Centre/Southhampton General Hospital, SouthHampton